Join Us

We are 224,935 members in 83 forums discussing 163,793 topics.

Help with Abbreviations

Topic: Lynparza Better Than Standard Chemo for HER2-Neg Mets w BRCA

Forum: Genetic Testing —

ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, NBN, NF1, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53, and mismatch repair genes (MLH1, MSH2, MSH6, PMS2, EPCAM)

Posted on: Jun 15, 2017 03:58PM

Moderators wrote:

Lynparza Better Than Standard Chemotherapy for HER2-Negative Metastatic Breast Cancer in Women With BRCA Mutations
June 15, 2017

A study found that Lynparza improved progression-free survival by about 3 months in women diagnosed with metastatic, HER2-negative breast cancer who had a BRCA1 or BRCA2 mutation. Read more...

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply